Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

This early-stage study tests a new tablet called VB19055 in 86 healthy Chinese adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo. The goal is to gather initial safety data before testing in people with high blood pre…